Get the Stockscreener App
30.93
3.70%
-1.19
Twist Bioscience Corp stock is traded at $30.93, with a volume of 1.00M.
It is down -3.70% in the last 24 hours and down -2.95% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$32.12
Open:
$32.12
24h Volume:
1.00M
Relative Volume:
0.58
Market Cap:
$1.89B
Revenue:
$362.27M
Net Income/Loss:
$-85.19M
P/E Ratio:
-21.33
EPS:
-1.45
Net Cash Flow:
$-68.71M
1W Performance:
-4.24%
1M Performance:
-2.95%
6M Performance:
-8.03%
1Y Performance:
-34.73%
1-Day Range:
$30.71
$32.73
1-Week Range:
$30.71
$33.31
52-Week Range:
$23.30
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
30.93 | 1.96B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Corporation $TWST Stock Holdings Lifted by EdgePoint Investment Group Inc. - MarketBeat
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights - Barchart.com
DNA Computing Market - GlobeNewswire Inc.
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest - Yahoo Finance
How Twist’s New Preclinical-Grade Plasmid DNA Preps Could Reshape the TWST Nucleic Acid Therapeutics Story - Yahoo Finance
Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST? - simplywall.st
Twist Bioscience Corp. Hits New 52-Week Low at $23.50 - Markets Mojo
Twist Bioscience Introduces New Plasmid DNA Preparation Products - marketscreener.com
Can Twist Bioscience Corporation (0ME) stock survive global slowdown2025 Risk Factors & Free Safe Entry Trade Signal Reports - Newser
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Business Wire
How analysts revise price targets for Twist Bioscience Corporation (0ME) stockStock Surge & Safe Swing Trade Setups - Newser
Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare - GlobeNewswire Inc.
A 'renter’s market' allowed this CEO to bring everyone together for lessSan Francisco Business Times - The Business Journals
Franklin Resources Inc. Decreases Stock Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corporation $TWST Stake Raised by XTX Topco Ltd - MarketBeat
Published on: 2025-11-28 09:12:39 - moha.gov.vn
Twist Bioscience Corp. Hits Day High with 9.55% Surge in Stock Price - Markets Mojo
Twist Bioscience Stock Hits Day Low of $25.51 Amid Price Pressure - Markets Mojo
Twist Bioscience Opens Weak with 10.57% Gap Down Amid Market Concerns - Markets Mojo
Ensign Peak Advisors Inc Has $6.08 Million Stock Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading 7.9% HigherHere's What Happened - MarketBeat
Insider Sell Alert: Jan Johannessen Sells Shares of Twist Biosci - GuruFocus
Can Twist Bioscience Corporation (0ME) stock reach $200 price targetWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com
Envestnet Asset Management Inc. Has $1.53 Million Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Can Twist Bioscience Corporation stock surprise with earnings upside2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Why Twist Bioscience Corporation (0ME) stock could outperform next year - newser.com
Live market analysis of Twist Bioscience CorporationEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com
What does recent volatility data suggest for Twist Bioscience CorporationQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Is Twist Bioscience Corporation (0ME) stock undervalued at current priceMarket Sentiment Summary & Fast Momentum Stock Entry Tips - newser.com
Will Twist Bioscience Corporation (0ME) stock hit analyst forecastsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value estimate for Twist Bioscience Corporation (0ME) stock in 2025CPI Data & Weekly Top Performers Watchlists - newser.com
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT - Finviz
What Indicators Suggest Overbought Oversold Levels in Ascensive Educare LimitedHead and Shoulders Patterns & Get Free Training on Technical Indicators - earlytimes.in
What analysts say about Twist Bioscience Corporation stockTrading Psychology Tips & Exceptional Return Growth - earlytimes.in
Decoding Twist Bioscience Corp (TWST): A Strategic SWOT Insight - GuruFocus
Twist Bioscience at Wolfe Research Conference: Strategic Growth Amid Challenges - Investing.com
Barclays Lowers Price Target for Twist Bioscience (TWST) to $37. - GuruFocus
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? - Insider Monkey
Twist Bioscience Corp SEC 10-K Report - TradingView
Twist Bioscience (BIT:1TWST) Price Target Decreased by 11.71% to 31.98 - Nasdaq
Will Twist Bioscience Corporation outperform the marketJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced - Yahoo Finance
Twist Bioscience Bets On Synthetic DNA As Growth Engine - Finimize
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience stock hits 52-week low at 23.85 USD By Investing.com - Investing.com Canada
Cathie Wood’s ARK trims Pinterest stock, adds to Bitmine and Twist Bioscience - Investing.com India
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):